Evoke Wealth’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Evoke Wealth’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-75	Closed	-$6K	–	1305
2022 Q2	$6K	Buy	+75	New	+$3.33K	﹤0.01%	877

Evoke Wealth's TPTX Position: Q3 2022 in Review

Evoke Wealth sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 75 shares — an estimated $6K sold.

Evoke Wealth first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $6K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Evoke Wealth reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Evoke Wealth sold 75 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $6K.
Evoke Wealth first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Evoke Wealth's Turning Point Therapeutics, Inc. Common Stock position peaked at $6K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Evoke Wealth's 13F filing for Q3 2022, filed 7 Nov 2022.